20-12-2023 01:50 PM | Source: Sushil Finance
 Ltd.jpg)
Neutral Kilitch Drugs (India) Ltd for Target Rs. 393 - Sushil Finance
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
We have coverage on Kilitch Drugs (India) Ltd. with a BUY rating on stock. Since our report, the stock has posted a high of Rs.381 today.
With the recent run-up in the share price (27% return), we are now changing our rating on the stock to Neutral.
Please refer disclaimer at https://www.sushilfinance.com/Disclamier/disclaimer
Member : BSE/ NSE/ MSEI. SEBI Registration No.-INZ000165135.
To Read Complete Report &
Disclaimer
Click Here
Views express by all participants are for information & academic purpose only. Kindly read
disclaimer before referring below views. Click Here For Disclaimer
Latest News
Centre launches portal for nurturing skill developme...
Hyundai, Kia`s Europe sales down 7.5 pc in October
AI-powered voice analysis may revolutionise early di...
Rohit Sharma to join Indian team in Australia on Sunday
Evening Roundup : A Daily Report on Bullion Energy &...
Buy Copper Above 825 SL Below 821 TGT 830/833 - Axis...
Over 9 in 10 Indian leaders anticipate an increase i...
Evening Track : Renewed Geopolitical uncertainty fue...
Mahayuti government is going to be formed: Shiv Sena...
Everything will get clear on the 23rd: BJPs Rahul Na...
